BioSpace News Archive

KoKo, a developer of respiratory information systems software and medical devices, and EirMed today announced a joint manufacturing partnership.

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

The report highlights the trends prevailing in the global critical care equipment market, and drivers and deterrents pertaining to the market growth.

SoundBite Medical Solutions Inc., a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, announced the use of its novel Active Wire 0.014” platform at a first site in the United States in the successful treatment of patients suffering from critical limb ischemia with heavily calcified lower limb chronic total occlusions.

Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that the U.S. Food and Drug Administration (“FDA”) has accepted for filing Amryt’s New Drug Application (“NDA”) for Oleogel-S10 for the treatment of Epidermolysis Bullosa (“EB”

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment of Lisa Wright to its Board of Directors, effective immediately.

Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive Officer, will make a presentation at the Stifel 2021 Virtual Cross Sector Insight Conference at 9:20 a.m. ET on Thursday, June 10, 2021 and will also be available to conduct one-on-one meetings throughout the day.

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held in a virtual format from June 4 to 8, 2021.

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced initial results from an automation study of its CRISPR-based test for SARS-CoV-2 in partnership with NorDx Laboratories